Literature DB >> 21088993

Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress.

Robert Manka1, Cosima Jahnke, Rolf Gebker, Bernhard Schnackenburg, Ingo Paetsch.   

Abstract

To directly compare the stressor capabilities of adenosine and high-dose dobutamine/atropine using first pass myocardial perfusion magnetic resonance imaging. Fourty-one patients with suspected or known coronary artery disease underwent cardiac magnetic resonance (CMR) perfusion imaging at 1.5 Tesla on two consecutive days prior to invasive coronary angiography. On day 1 a standard CMR perfusion protocol during adenosine stress was carried out (adenosine infusion with 140 μg/kg/min, 0.1 mmol/kg Gd-DTPA). On day 2, the identical CMR perfusion sequence was repeated during a standard high-dose dobutamine/atropine stress protocol at rest and during target heart rate (85% of maximum age-predicted heart rate). Stress-inducible perfusion deficits were evaluated visually regarding presence and transmural extent. Quantitative coronary angiography served as the reference standard with significant stenosis defined as ≥50% luminal diameter reduction. Twenty-five patients (61%) had significant coronary stenoses. Adenosine and dobutamine stress CMR perfusion imaging resulted in an equally high sensitivity and specificity for the stenosis detection on a per patient basis (92 and 75% for both stressors, respectively). Agreement of both stressors with regard to the presence or absence of stress-inducible perfusion deficits was nearly perfect using patient- and segment based analysis (kappa 1.0 and 0.92, respectively). Adenosine and dobutamine/atropine stress CMR perfusion imaging are equally capable to identify stress inducible deficits and resulted in an almost identical extent of ischemic reactions. Though adenosine stress CMR perfusion imaging is widely employed, dobutamine stress CMR perfusion represents a valid alternative and may be particularly useful in patients with contraindications to vasodilator testing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088993     DOI: 10.1007/s10554-010-9748-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  21 in total

1.  Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.

Authors:  Igor Klem; John F Heitner; Dipan J Shah; Michael H Sketch; Victor Behar; Jonathan Weinsaft; Peter Cawley; Michele Parker; Michael Elliott; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

2.  Prediction of necessity for coronary artery revascularization by adenosine contrast-enhanced magnetic resonance imaging.

Authors:  Peter Bernhardt; Thomas Engels; Benny Levenson; Katrin Haase; Alexander Albrecht; Oliver Strohm
Journal:  Int J Cardiol       Date:  2005-11-04       Impact factor: 4.164

Review 3.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.

Authors:  Cosima Jahnke; Eike Nagel; Rolf Gebker; Thomas Kokocinski; Sebastian Kelle; Robert Manka; Eckart Fleck; Ingo Paetsch
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

6.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

7.  MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial.

Authors:  Juerg Schwitter; Christian M Wacker; Albert C van Rossum; Massimo Lombardi; Nidal Al-Saadi; Hakan Ahlstrom; Thorsten Dill; Henrik B W Larsson; Scott D Flamm; Moritz Marquardt; Lars Johansson
Journal:  Eur Heart J       Date:  2008-01-21       Impact factor: 29.983

8.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

9.  Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.

Authors:  Stuart Watkins; Ross McGeoch; Jonathan Lyne; Tracey Steedman; Richard Good; Mairi-Jean McLaughlin; Tony Cunningham; Vladimir Bezlyak; Ian Ford; Henry J Dargie; Keith G Oldroyd
Journal:  Circulation       Date:  2009-11-16       Impact factor: 29.690

10.  Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease.

Authors:  Rolf Gebker; Cosima Jahnke; Robert Manka; Ashraf Hamdan; Bernhard Schnackenburg; Eckart Fleck; Ingo Paetsch
Journal:  Circ Cardiovasc Imaging       Date:  2008-07-30       Impact factor: 7.792

View more
  7 in total

1.  Value of additional myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of intermediate coronary artery disease.

Authors:  Rolf Gebker; M Frick; C Jahnke; A Berger; C Schneeweis; R Manka; S Kelle; C Klein; B Schnackenburg; E Fleck; I Paetsch
Journal:  Int J Cardiovasc Imaging       Date:  2010-12-14       Impact factor: 2.357

Review 2.  Cardiac MR perfusion imaging: where we are.

Authors:  Riccardo Marano; Luigi Natale; Amedeo Chiribiri; Federica Pirro; Valentina Silvestri; Giuseppe Coppola; Lorenzo Bonomo
Journal:  Radiol Med       Date:  2014-07-17       Impact factor: 3.469

Review 3.  The role of stress cardiac magnetic resonance in women.

Authors:  Andrea Cardona; Karolina M Zareba; Subha V Raman
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

Review 4.  Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging.

Authors:  Ricardo A Costa; Hiram G Bezerra; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2012-03       Impact factor: 2.357

Review 5.  Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques.

Authors:  James R J Foley; Sven Plein; John P Greenwood
Journal:  World J Cardiol       Date:  2017-02-26

6.  Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure.

Authors:  Nikolaj Bøgh; Esben S S Hansen; Camilla Omann; Jakob Lindhardt; Per M Nielsen; Robert S Stephenson; Christoffer Laustsen; Vibeke E Hjortdal; Peter Agger
Journal:  Sci Rep       Date:  2020-05-18       Impact factor: 4.379

Review 7.  Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions.

Authors:  Andreas Seraphim; Kristopher D Knott; Joao B Augusto; Katia Menacho; Sara Tyebally; Benjamin Dowsing; Sanjeev Bhattacharyya; Leon J Menezes; Daniel A Jones; Rakesh Uppal; James C Moon; Charlotte Manisty
Journal:  Front Cardiovasc Med       Date:  2021-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.